Neurelis acquired Aegis Therapeutics.

Neurelis, a neuroscience-based pharmaceutical company, acquired Aegis Therapeutics, a San Diego-based drug delivery technology company. Ed Maggio, CEO of Aegis Therapeutics added, “We are thankful to have been a part of the important work in progressing these programs with our strategic partners over the years. In the coming months, we have the potential of seeing the first two products incorporating the Intravail technology approved by the FDA. Given our longstanding relationship with Neurelis and their appreciation for the value of Intravail, we are excited for the next chapters of success with these novel technologies.”